Long term survival after Rhodococcus equi pneumonia in a patient wtth human immunodeficiency virus infection in the era of highly active antiretroviral therapy: Case report and review;Dugoročno preživljavanje nakon pneumonije uzrokovane Rhodococcus equi bolesnika zaraženog virusom humane imunodeficijencije u eri vrlo učinkovitog antiretrovirusnog liječenja: Prikaz bolesnika i pregled literature

Acta Medica Croatica

Volumn 60, Issue 3, 2006, Pages 259-263

  Vladušić, Ivona ^a   Krajinović, Vladimir ^a   Begovac, Josip ^a  

^a Croatia   (Croatia)

Author keywords

AIDS; Azithromycin; HIV; Pneumonia; Rhodococcus equi

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; AZITHROMYCIN; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; IMIPENEM; IMMUNOSUPPRESSIVE ACID PROTEIN; LEVOFLOXACIN; RIFAMPICIN; VANCOMYCIN; VIRUS RNA;

ADULT; ANAMNESIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CASE REPORT; CD4 LYMPHOCYTE COUNT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION PROCEDURE; LONG TERM CARE; LUNG CAVITATION; MALE; PNEUMONIA; PRESCRIPTION; REMISSION; RHODOCOCCUS EQUI; SPUTUM ANALYSIS; SURVIVAL; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; VIRUS LOAD; AIDS RELATED COMPLEX; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MIDDLE AGED; REVIEW;

ACTINOMYCETALES INFECTIONS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; AZITHROMYCIN; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; RHODOCOCCUS EQUI;

EID: 33750584066     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Torres-Tortosa M, Arrizabalaga J, Villanueva JL i sur. Prognosis and clinical evaluation of infection caused by Rhodococcus equi in HIV-infected patients. Chest 2003; 123: 1970-76.
2. Donisi A, Suardi MG, Casari S, Longo M, Cadeo GP, Carosi G. Rhodococcus equi infection in HIV-infected patients. AIDS 1996; 10: 359-62.
3. Brown E. Other Corynebacteria and Rhodococcus. U: Mandell G, Bennett J, Dolin R, ur. Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone, 2000, 2198-2200.
4. Arlotti M, Zoboli G, Moscatelli GL i sur. Rhodococcus equi infection in HIV-positive subjects: a retrospective analysis of 24 cases. Scand J Infect Dis 1996; 28: 463-7.
5. Giola M, Basilico C, Dinatale F, Montanari M, Grossi PA. Rhodococcus equi pneumonia: long-term survival with HAART and specific therapy. U: Abstracts presented at the 2nd IAS Conference on HIV Pathogenesis and Treatment. Paris, 2003, Abstract no. 918.
6. Moretti F, Quiros-Roldan E, Casari S, Viale P, Chiodera A, Carosi G. Rhodococcus equi: pulmonary cavitation lesion in patient infected with HIV cured by levofloxacin and rifampicin. AIDS 2002; 16: 1440-2.
7. Sanz-Moreno J, Flores-Segovia J, Olmedilla-Arregui G, Gomez-Herruz P, Granell J. Rhodococcus equi pneumonia: highly active antiretroviral therapy helps but does not cure lung infection. AIDS 2002; 16: 509-11.
8. Nordmann P, Rouveix E, Guenounon M i sur. Pulmonary abscess due to rifampin and fluoroquinolone resistent Rliodococcus equi stain in a HIV-infected patient. Eur J Clin Microb Infect Dis 1992; 11: 557-8.
9. Scotton PG, Tonon E, Giobbia M, Gallucci M, Rigoli R, Vaglia A. Rhodococcus equi nosocomial meningitis cured by levofloxacin and shunt removal. Clin Infect Dis 2000; 30: 223-4.
10. Kwa AL, Tam VH, Rybak MJ. Rhodococcus equi pneumonia in a patient with human immunodeficiency virus: case report and review. Pharmacotherapy 2001; 21: 998-1002.